azauridine has been researched along with Leukemia, Myeloid, Acute in 2 studies
Azauridine: A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grignani, F | 1 |
Martelli, M | 1 |
Tonato, M | 1 |
Fleming, I | 1 |
Simone, J | 1 |
Jackson, R | 1 |
Johnson, W | 1 |
Walters, T | 1 |
Mason, C | 1 |
2 other studies available for azauridine and Leukemia, Myeloid, Acute
Article | Year |
---|---|
[Antimetabolites in the treatment of acute human leukoses. Mechanism of action and conditioning factors in the cellular response to drugs. II].
Topics: Antimetabolites; Azacitidine; Azaguanine; Azauridine; Cell Membrane Permeability; Cytarabine; DNA, N | 1974 |
Proceedings: Splenectomy and chemotherapy in acute myelocytic leukemia of childhood.
Topics: Adolescent; Adult; Age Factors; Azauridine; Child; Child, Preschool; Cytarabine; Drug Therapy, Combi | 1974 |